McPherson's eyes top-line growth after portfolio pivot скачать в хорошем качестве

McPherson's eyes top-line growth after portfolio pivot

McPherson’s (ASX:MCP) is pushing forward with a comprehensive transformation, targeting a sharper focus on health, wellness, and beauty categories to secure market share through pharmacy and grocery channels. CEO Brett Charlton and CFO Mark Sherwin outline a strategic shift that sees the business exit legacy segments, notably through the sale of the Multix brand, consolidating its portfolio around established names such as Manicare, Lady Jayne, Dr. Lewin’s, and Fusion. This pivot has allowed McPherson’s to streamline operations, shed fixed costs, and enhance its sales and marketing capabilities. CFO Sherwin points to an encouraging $2.7 million in cost savings achieved in the first half, part of a broader $4.5–5 million target. He says the transition is evident in mixed revenue performance across brands, with some facing short-term supply challenges, but key categories remain resilient. Sherwin highlights a buyback initiative as a strong signal of confidence in the ongoing strategy, supporting shareholder value as the business withholds an interim dividend to stabilise post-transformation. CEO Charlton says that everyday essentials underpin McPherson’s defensive positioning, with products found in four out of five Australian households. Emphasis now shifts to top-line growth through improved marketing, further expansion, and leveraging digital tools including AI. Sherwin confirms the company’s balance sheet remains strong, with no debt and a robust net cash position.